横纹肌溶解与补体:上皮细胞再次成为焦点
横纹肌溶解常伴肾损伤且缺乏特异性治疗,以支持治疗为主。Boudhabhay等在Kidney International报道,受损骨骼肌释放的肌红蛋白触发肾小管间质补体活化;小鼠模型中清除游离血红素或阻止补体活化可减轻肾损伤,提示这些策略可能有效。
要点
- 肌红蛋白触发肾小管间质补体活化是横纹肌溶解肾损伤的关键机制。
- 小鼠模型中清除游离血红素或阻断补体活化可减轻肾损伤。
- 该机制为横纹肌溶解相关肾损伤提供了潜在特异性治疗靶点。
核心结论
- 肌红蛋白释放触发肾小管间质补体活化,清除游离血红素或阻止补体活化可改善小鼠肾损伤,提示潜在治疗策略。
主要发现
- 受损骨骼肌释放的肌红蛋白触发肾小管间质补体活化。
- 小鼠模型中清除游离血红素或阻止补体活化可减轻肾损伤。
临床怎么用
- 目前临床仍以支持治疗为主,上述干预策略尚需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rhabdomyolysis is frequently associated with kidney injury. Unfortunately, there are no specific treatments for this condition, and patient care primarily consists of supportive measures. In this edition of Kidney International, Boudhabhay et al. demonstrate that myoglobin released from injured skeletal muscle cells triggers tubulointerstitial complement activation. In a mouse model of the disease, interventions that scavenged free heme or that prevented complement activation ameliorated kidney injury, raising the possibility that these strategies may be effective treatments for the condition.
引用
- Thurman JM. Rhabdomyolysis and complement-once again, epithelial cells take center stage. Kidney Int. 2021. PMID: 33637198. doi:10.1016/j.kint.2020.10.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。